$84.76
-0.50-0.59%
Últ. Act.: Sep 14, 10:11 AM
GeneDx Holdings Corp
WGSNASDAQ
GeneDx Holdings Earnings & Forecasts
GeneDx Holdings (WGS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
GeneDx Holdings Guidance
GeneDx Holdings (WGS) publicó su última previsión de agosto 3, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $475M - $490M para el período.
En comparación con la previsión anterior, GeneDx Holdings mantenido redujo su previsión de ingresos desde un rango anterior de $475M - $490M.
GeneDx Holdings ha emitido 18 actualizaciones de orientación entre el marzo 14, 2023 y el agosto 3, 2026. During this period, the company raised its outlook 9 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.19 | $-0.03 | $0.12 | $0.37 |
| Actual | $0.01 | $-0.28 | $0.14 | $0.49 |
| Surprise | +105.3% | -833.3% | +16.7% | +32.4% |
| Revenue | ||||
| Estimate | $110.7M | $112.1M | $119.9M | $104.3M |
| Actual | $114.4M | $102.3M | $121.0M | $116.7M |
| Surprise | +3.33% | -8.71% | +0.87% | +11.9% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.07 | $0.31 | $0.10 | $0.25 |
| Revenue | ||||
| Consensus | $122.8M | $141.6M | — | — |